
Amanda Nizam, MD
@amandanizammd
GU Medical Oncologist @ClevelandClinic | Bladder, kidney, & prostate Ca | Tx-related toxicity | @ASCOTECAG & @GWSMHS alum | 🌎 citizen | Views my own | COI ⬇️
ID: 106342723
https://coi.asco.org/share/VF7-WR44/Amanda%20Nizam 19-01-2010 07:22:54
4,4K Tweet
1,1K Takipçi
1,1K Takip Edilen










New editorial led by Robin Yabroff comments on a recent report finding that up-to-date colorectal cancer screening increased most in Medicaid expansion states w/ paid leave laws relative to nonexpansion states w/o paid leave laws. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert


We have life saving cancer drugs and life threatening shortages. Julie Gralow, ASCO staff, and I discuss why, and potential solutions in JCO Oncology Practice: ascopubs.org/doi/10.1200/OP…



🚀 Now enrolling MD Anderson Cancer Center: IVORY trial of #ivonescimab (first-in-class PD1×VEGF bispecific) in metastatic clear cell #KidneyCancer after prior IO±TKI. Hypothesis: cooperative inhibition of PD1/VEGF signaling will restore treatment sensitivity 👉 clinicaltrials.gov/study/NCT06940…


ctDNA can help guide adjuvant decision making in MIBC In pts with undetectable ctDNA after NAC + cystectomy, no definitive benefit for adjuvant ICB authors.elsevier.com/c/1lMET14kpm0h… Matt Galsky The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Uromigos Bladder Cancer Advocacy Network UroToday.com World Bladder Cancer Patient Coalition OncLive.com




“Despite our flawed instinct to take the path of least resistance,” writes Dr. Arthur Brooks of Cicero's great life lesson, “we will always be better served by choosing to do the right thing”: theatlantic.com/ideas/archive/…

🙋♀️Hello!! How's your schedule this fall? 🌟#WomenInOncology, save Sep 27-28 for #LEAD25! It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology! 👉 bioascend.com/lead/ Dr. Julie Brahmer Ana I. Velázquez Mañana, MD, MSc, FASCO Dr. Catherine Lai

